Back
Apellis Pharmaceuticals Quote, Financials, Valuation and Earnings
Sell
34
APLS
Apellis Pharmaceuticals
Last Price:
42.58
Seasonality Move:
4.47%
7 Day Trial
ALL ACCESS PASS
$
7
Apellis Pharmaceuticals Price Quote
$42.58
-0.64 (-1.48%)
(Updated: May 21, 2024 at 4:55 PM ET)
Apellis Pharmaceuticals Key Stats
Sell
34
Apellis Pharmaceuticals (APLS)
is a Sell
Day range:
$40.99 - $43.29
52-week range:
$19.83 - $94.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
9.97
P/B ratio:
19.67%
Volume:
876K
Avg. volume:
1.6M
1-year change:
-51.36%
Market cap:
$5.2B
Revenue:
$396.6M
EPS:
$-3.46
How Much Does Apellis Pharmaceuticals Make?
-
How Much Are Apellis Pharmaceuticals's Sales Annually?
APLS Revenues are $396.6M -
How Much Profit Does Apellis Pharmaceuticals's Make A Year?
APLS net income is -$528.6M
Is Apellis Pharmaceuticals Growing As A Company?
-
What Is Apellis Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 2.84% -
What Is Apellis Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Apellis Pharmaceuticals Stock Price Performance
-
Did Apellis Pharmaceuticals Stock Go Up Last Month?
Apellis Pharmaceuticals share price went down by -9.07% last month -
Did APLS's Share Price Rise Over The Last Year?
APLS share price fell by -51.36% over the past 1 year
What Is Apellis Pharmaceuticals 52-Week High & Low?
-
What Is Apellis Pharmaceuticals’s 52-Week High Share Price?
Apellis Pharmaceuticals has traded as high as $94.75 over the past 52 weeks -
What Is Apellis Pharmaceuticals’s 52-Week Low Share Price?
Apellis Pharmaceuticals has traded as low as $19.83 over the past 52 weeks
Apellis Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Apellis Pharmaceuticals?
-
How Much Debt Does Apellis Pharmaceuticals Have?
Total long term debt quarterly is $93.1M -
How Much Cash Does Apellis Pharmaceuticals Have?
Cash and short term investments quarterly total is $325.9M -
What Is Apellis Pharmaceuticals’s Book Value Per Share?
Book value per share is 2.20
Is Apellis Pharmaceuticals Cash Flow Positive?
-
What Is APLS Cash Flow From Operations?
Cash flow from operations (TTM) is -$550.1M -
What Is Apellis Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $111.6M -
What Is Apellis Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$708K
Apellis Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
APLS return on invested capital is -108.9% -
What Is Apellis Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -48.15% -
What Is APLS Return On Equity?
ROE is a measure of profitability and is -143.79%
Apellis Pharmaceuticals Earnings Date & Stock Price
-
What Is Apellis Pharmaceuticals's Stock Price Today?
A single share of APLS can be purchased today for 43.22 -
What Is Apellis Pharmaceuticals’s Stock Symbol?
Apellis Pharmaceuticals trades on the nasdaq under the ticker symbol: APLS -
When Is Apellis Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Apellis Pharmaceuticals is scheduled on July 31, 2024 -
When Is APLS's next ex-dividend date?
Apellis Pharmaceuticals's next ex-dividend date is May 21, 2024 -
How To Buy Apellis Pharmaceuticals Stock?
You can buy Apellis Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Apellis Pharmaceuticals Competitors
-
Who Are Apellis Pharmaceuticals's Competitors?
Below is a list of companies who compete with Apellis Pharmaceuticals or are related in some way:
Apellis Pharmaceuticals Dividend Yield
Data Unavailable
Apellis Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -30.94% |
| Revenue: | 284.26% | 4.91% |
Analyst Recommendations
| Buy Recommendations: | 10 |
|---|---|
| Hold Recommendations: | 3 |
| Sell Recommendations: | 0 |
| Price Target: | 80.06 |
| Upside from Last Price: | 85.24% |